Claridge, 2014 - Google Patents
Overexpressing Gαs in Osteoblasts in vitro and in vivo: Effects on Basal and PTH-Stimulated Gene ExpressionClaridge, 2014
View PDF- Document ID
- 6450955468637609419
- Author
- Claridge C
- Publication year
External Links
Snippet
Previous work in our laboratory showed altered signaling through the parathyroid hormone (PTH) receptor when Gα 11 was overexpressed in osteoblasts. To examine the effect of Gα s overexpression on PTH signaling, we transfected Gas long into UMR osteoblastic cells and …
- 102000034429 Gs proteins 0 title abstract description 379
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cheatham et al. | Insulin action and the insulin signaling network | |
| Bassett et al. | Critical role of the hypothalamic–pituitary–thyroid axis in bone | |
| Yang et al. | RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+] i oscillation regulation | |
| Klugmann et al. | AAV-mediated hippocampal expression of short and long Homer 1 proteins differentially affect cognition and seizure activity in adult rats | |
| Akiyama et al. | Interactions between Sox9 and β-catenin control chondrocyte differentiation | |
| WO1996023001A1 (en) | New pharmaceuticals for modulating hormone responsiveness | |
| US20060035849A1 (en) | Methods and composition for modulating type I muscle formation using pgc-1 alpha | |
| Spurney et al. | Anabolic effects of a G protein–coupled receptor kinase inhibitor expressed in osteoblasts | |
| JP2002525602A (en) | GPR10 as a target for identifying compounds that modulate body weight | |
| WO2008109779A2 (en) | Use of follistatin-like related gene (flrg) to increase muscle mass | |
| Hocker et al. | Gastrin regulates the human histidine decarboxylase promoter through an AP-1-dependent mechanism | |
| Bisikirska et al. | Melatonin receptor 1A variants as genetic cause of idiopathic osteoporosis | |
| JP2002536997A (en) | Novel G protein-coupled receptor 14273 receptor | |
| Bennett et al. | Odor-evoked gene regulation and visualization in olfactory receptor neurons | |
| CA2253433A1 (en) | Mammalian regulator of nonsense-mediated rna decay | |
| JP2008536869A (en) | Method of modulating bone formation and mineralization by modulating KRC activity | |
| CA2522718A1 (en) | A novel method of modulating bone-related activity | |
| US7314716B2 (en) | Gustducin γ subunit materials and methods | |
| Claridge | Overexpressing Gαs in Osteoblasts in vitro and in vivo: Effects on Basal and PTH-Stimulated Gene Expression | |
| Höcker et al. | Neuroendocrine-specific and gastrin-dependent expression of a chromogranin A-luciferase fusion gene in transgenic mice | |
| JP2002523056A (en) | Homer interacting protein | |
| Rybkin et al. | Regulation of atrial natriuretic peptide secretion by a novel Ras-like protein | |
| WO2002077229A2 (en) | Cofactors of the liver x receptor alpha and methods of use | |
| JP2004524802A (en) | PH domain interacting protein | |
| EP1228209B1 (en) | "insulin-responsive sequence dna binding protein-1" (irsdbp-1), gene encoding it and uses thereof |